Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

Item

http://www.wikidata.org/entity/Q36685452

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

@ast

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

@en

type

Item

label

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

@ast

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

@en

prefLabel

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

@ast

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

@en

P1476

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.

@en

P2093

Anteneh Tesfaye

http://www.w3.org/2001/XMLSchema#string

Brandon G Smaglo

http://www.w3.org/2001/XMLSchema#string

David Arguello

http://www.w3.org/2001/XMLSchema#string

Joshua E Meyer

http://www.w3.org/2001/XMLSchema#string

Jue Wang

http://www.w3.org/2001/XMLSchema#string

Patrick M Boland

http://www.w3.org/2001/XMLSchema#string

Sandeep Reddy

http://www.w3.org/2001/XMLSchema#string

Thorvardur R Halfdanarson

http://www.w3.org/2001/XMLSchema#string

Zoran Gatalica

http://www.w3.org/2001/XMLSchema#string

P2860

Human papilloma virus and squamous cell carcinoma of the anus

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies.

Cancer statistics, 2015

Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.

Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.

Anal cancer treatment: current status and future perspectives.

Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy.

The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal.

The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

P304

43594-43604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6202

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283261377

http://www.w3.org/2001/XMLSchema#string

P698

26498363

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4791253

http://www.w3.org/2001/XMLSchema#string